University of Hawaii Manoa: Immunotherapy Shows Promise for Aggressive Breast Cancer
April 17, 2024
April 17, 2024
MANOA, Hawaii, April 17 (TNSres) -- The University of Hawaii Manoa campus issued the following news release:
University of Hawaii Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The trial was led by Naoto T. Ueno, UH Cancer Center director, and Toshiaki Iwase, assistant professor and medical director, and was conducted at their former in . . .
University of Hawaii Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The trial was led by Naoto T. Ueno, UH Cancer Center director, and Toshiaki Iwase, assistant professor and medical director, and was conducted at their former in . . .